Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Scientific Reports|March 19, 2021
Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugateBenedikt Feuerecker, Philipp Biechl, Christof Seidl, et al.
EJNMMI Radiopharmacy and Chemistry|July 21, 2026
Inline gamma spectroscopy and liquid scintillation HPLC reveal daughters in 225Ac-radiopharmaceuticalGuilhem Claude, Matthias Balzer, Winfried Brenner, et al.
Scientific Reports|June 6, 2019
Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDGBenedikt Feuerecker, Michael Michalik, Christian Hundshammer, et al.
Chemmedchem|July 3, 2020
First-Generation Bispidine Chelators for 213 BiIII Radiopharmaceutical ApplicationsFrank Bruchertseifer, Peter Comba, Bodo Martin, et al.
EJNMMI Research|August 10, 2018
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeuticsJakub Šimeček, Petr Hermann, Christof Seidl, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 24, 2017
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in RadiotherapyAlexander Wurzer, Christof Seidl, Alfred Morgenstern, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 13, 2018
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor ControlClemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, et al.
Angewandte Chemie (International Ed. in English)|June 4, 2026
Chelator-Free Radiometal Labeling Inside Engineered AffibodiesLani J Davies, Upamali Somathilake, Santhanalaxmi Kumaresan, et al.
Nuclear Medicine and Biology|March 3, 2012
High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumChristian Rauch, Christof Seidl, Martin Schlapschy, et al.
Nuclear Medicine and Biology|April 10, 2024
Development of 225Ac/213Bi generator based on α-ZrP-PAN composite for targeted alpha therapyLukáš Ondrák, Kateřina Ondrák Fialová, Michal Sakmár, et al.
Pageof 18